These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6297526)

  • 21. [Antiarrhythmic effects of prostaglandins F2alpha, E2, and A2 on CaCl2-and aconitine-arrhythmias].
    Mentz P; Förster W
    Acta Biol Med Ger; 1974; 32(4):393-402. PubMed ID: 4408576
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gate mechanism of calcium channels: stationary characteristics and kinetics].
    Kostiuk PG; Kryshtal' Pidoplichko VI; Shakhovalov IuA
    Dokl Akad Nauk SSSR; 1979; 249(6):1470-3. PubMed ID: 527474
    [No Abstract]   [Full Text] [Related]  

  • 23. [Arrhythmias due to myocardial injury].
    Hirano Y; Hiraoka M
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1890-7. PubMed ID: 2236603
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrophysiologic effects of magnesium chloride on the Purkinje fibers of the dog].
    Berdeja García GY; Pastelín G
    Arch Inst Cardiol Mex; 1982; 52(6):453-60. PubMed ID: 7159126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of ethmozine and its diethylamino analog on the slow incurrent and excurrent ion flows of cardiac atrial fibers].
    Rozenshtraukh LV; Chikharev VN
    Biull Eksp Biol Med; 1980 Sep; 90(9):303-5. PubMed ID: 7000199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electrophysiological study of the antiarrhythmic effect of dimethindene (Fenistil)].
    Mészáros J; Szegi J
    Acta Pharm Hung; 1984 Jul; 54(4):160-9. PubMed ID: 6091407
    [No Abstract]   [Full Text] [Related]  

  • 28. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
    Nakaya H
    Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
    [No Abstract]   [Full Text] [Related]  

  • 29. [Molecular mechanisms of the interaction of diphenylhydantoin with biological membranes].
    Gurevich VS; Razumovskaia NI
    Farmakol Toksikol; 1984; 47(1):114-9. PubMed ID: 6323211
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dependence of the protonophore and channel-forming capacity of gossypol on the pH].
    Krasil'nikov OV; Zaripova RK; Kalaĭdzhian VA; Tashmukhamedov BA
    Dokl Akad Nauk SSSR; 1985; 281(5):1245-7. PubMed ID: 2408838
    [No Abstract]   [Full Text] [Related]  

  • 31. [Validity of the study of the electrophysiological effects of anti-arrhythmia drugs in man prior to modern antiarrhythmic therapy. Multicenter study].
    Disertori M; Furlanello F; Botti G; Bonatti V; Critelli G; Adinolfi L; Lotto A; Finzi A; Masoni A; Alboni P; Rizzon P; Di Biase M; Salerno JA; Chimienti M; Costantini M; Santini M; Dini P
    Boll Soc Ital Cardiol; 1980; Suppl():101-15. PubMed ID: 6760884
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The membrane-tropic effect of drugs].
    Ignatov IuD; Vislobokov AI; Mel'nikov KN
    Vestn Ross Akad Med Nauk; 2004; (10):35-40. PubMed ID: 15575400
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiarrhythmics--from cell to clinic: past, present, and future.
    Hancox JC; Patel KC; Jones JV
    Heart; 2000 Jul; 84(1):14-24. PubMed ID: 10862579
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipids and membrane function: implications in arrhythmias.
    Katz AM; Messineo FC
    Hosp Pract (Off Ed); 1981 Jul; 16(7):49-59. PubMed ID: 6265339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current stage of pharmacological therapy in arrhythmias].
    Visioli O
    G Clin Med; 1973 Jul; 54(7):429-35. PubMed ID: 4779855
    [No Abstract]   [Full Text] [Related]  

  • 38. Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias.
    Hauswirth O; Singh BN
    Pharmacol Rev; 1978 Mar; 30(1):5-63. PubMed ID: 377312
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolonged action potentials in cardiac Purkinje cells: a distinct phenotype arising from a distinct sodium channel.
    Fearon IM; Gautier M
    Exp Physiol; 2007 Jan; 92(1):1-2. PubMed ID: 17099058
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms of disease: new mechanisms of antiarrhythmic actions.
    Gilmour RF; Zipes DP
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):37-41. PubMed ID: 16265258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.